SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-13
DOI
10.1038/srep27694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway
- (2015) HUA XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism
- (2015) Pedro Gomes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia
- (2015) Xiaoning Gao et al. PLoS One
- Angiogenesis and acute myeloid leukemia
- (2013) Houda Haouas Hematology
- HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
- (2013) M. H. Yang et al. MOLECULAR CANCER RESEARCH
- Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells
- (2013) Yoshitaka Sunami et al. PLoS One
- Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
- (2012) A. F. T. Ribeiro et al. BLOOD
- Mutational landscape of AML with normal cytogenetics: Biological and clinical implications
- (2012) Maria Paola Martelli et al. BLOOD REVIEWS
- Vascular endothelial growth factor signaling in acute myeloid leukemia
- (2012) Kim R. Kampen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance
- (2012) Michaël Van Damme et al. Epigenetics
- Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: Coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile
- (2011) Dante Rotili et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
- (2011) Hyun-Seok Kim et al. CANCER CELL
- The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells
- (2011) L. Dan et al. HAEMATOLOGICA
- Review: Pathobiological aspects of the local bone marrow renin-angiotensin system: a review
- (2010) Ibrahim C Haznedaroglu et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
- (2010) Ruth Luthi-Carter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of high-quality cancer prognostic markers and metastasis network modules
- (2010) Jie Li et al. Nature Communications
- p53 Activation: A Case against Sir
- (2008) Christopher L. Brooks et al. CANCER CELL
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now